metabolic
Mazdutide
GLP-1/glucagon dual agonist
0 vendors tracked0 live pricesLast crawl: warming up
About
A dual GLP-1 and glucagon receptor agonist in late-stage clinical development for obesity, type-2 diabetes, and metabolic-associated fatty liver disease.
Also known as: IBI-362, LY-3305677
Reconstitution calculator
!
For research purposes only. Not for human consumption. Always verify calculations independently.
Cost-per-dose recalculates as you adjust the calculator above.
Research use only. The compounds listed on this page are not approved for human use through research-chemical channels. Nothing on this page is medical advice. Consult a qualified clinician before considering any peptide protocol. See affiliate disclosure and our scoring methodology.
Keep exploring
More on Mazdutide & related research
Related peptides
- Tirzepatide— Dual GLP-1/GIP agonist
- Retatrutide— Triple GCG/GIP/GLP-1 agonist
- Survodutide— Glucagon/GLP-1 dual agonist
- Semaglutide— GLP-1 agonist for metabolic research
- Orforglipron— Oral small-molecule GLP-1 agonist
Compare head-to-head